山本 祥之(ヤマモト ヨシユキ)
- 論文
- Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer
Sudo Kentaro; Nakamura Yoshiaki; Ueno Makoto; Furukawa...
BRITISH JOURNAL OF CANCER/Epub, 2024-08-28 - Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group
Takashima Atsuo; Ishiguro Megumi; Sasaki Keita; Machid...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/Epub, 2024-08-29 - QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
Bando Hideaki; Kotani Daisuke; Satake Hironaga; Hamagu...
MED/5(9), 2024-09-13 - Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Hamano Jun; Higashibata Takahiro; Kessoku Takaomi; Kaj...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology/42(35)/p.JCO2400381, 2024-09-10 - A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
Matsumoto Toshihiko; Yamamoto Yoshiyuki; Kotaka Masahi...
TARGETED ONCOLOGY/19(2)/pp.181-190, 2024-03 - Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
Sunakawa Yu; Kuboki Yasutoshi; Watanabe Jun; Terazawa ...
TARGETED ONCOLOGY/19(1)/pp.59-69, 2024-01 - Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
Kajiwara Takeshi; Nishina Tomohiro; Yamashita Riu; Nak...
CANCERS/15(21), 2023-11 - Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)
Ando Koji; Nakamura Yoshiaki; Kitao Hiroyuki; Shimokaw...
BRITISH JOURNAL OF CANCER/129(6)/pp.1032-1039, 2023-10-05 - Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study
Mitani Seiichiro; Kito Yosuke; Hino Kaori; Kawakami K...
TARGETED ONCOLOGY/18(5)/pp.707-715, 2023-09 - Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis
Kaneko Takuya; Doki Kosuke; Yamada Takeshi; Yamamoto ...
CANCER CHEMOTHERAPY AND PHARMACOLOGY/92(4)/pp.271-278, 2023-10 - A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial
Izawa Naoki; Masuishi Toshiki; Takahashi Naoki; Shoji ...
TARGETED ONCOLOGY/18(3)/pp.369-381, 2023-05 - Gastric neuroendocrine carcinoma presenting complete durable response by nivolumab treatment for multiple metastases and radiotherapy to oligoprogressive metastasis
Seyama Yusuke; Yamada Takeshi; Suzuki Hirosumi; Fukuda...
INTERNATIONAL CANCER CONFERENCE JOURNAL/12(4)/pp.268-273, 2023-10 - Relationship Between Safety and Cumulative Bevacizumab Dose in Patients With Metastatic Colorectal Cancer Who Received Long-term Bevacizumab Treatment
Fukuda Satoshi; Niisato Yusuke; Tsuji Miki; Fukuda So...
ANTICANCER RESEARCH/43(5)/pp.2085-2090, 2023-05 - Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: a phase I/II study protocol (TT-LAP trial)
Shimomura Osamu; Endo Masato; Makishima Hirokazu; Yama...
BMC CANCER/23(1)/p.624, 2023-07-04 - Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan
Aoki Masahiko; Kadowaki Shigenori; Takahashi Naoki; Su...
GASTRIC CANCER/26(1)/pp.132-144, 2023-01 - Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged > 75 years
Moriwaki Toshikazu; Nishina Tomohiro; Sakai Yoshinori; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/52(7)/pp.717-726, 2022-07 - Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy
Mizukami Takuro; Takahashi Masaki; Sunakawa Yu; Yuki ...
TARGETED ONCOLOGY/17(3)/pp.343-353, 2022-05 - Distribution of therapeutic monoclonal antibodies into ascites in advanced gastric cancer patients with peritoneal metastasis: case reports and literature review
Kaneko Takuya; Doki Kosuke; Yamada Takeshi; Yamamoto ...
CANCER CHEMOTHERAPY AND PHARMACOLOGY/90(5)/pp.421-426, 2022-11-01 - Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy
Nakamura Yoshiaki; Okamoto Wataru; Denda Tadamichi; Ni...
JCO PRECISION ONCOLOGY/6, 2022-01-25 - Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol
Higashibata Takahiro; Hamano Jun; Kessoku Takaomi; Kaj...
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS/29, 2022-10-01 - Treatment of ruptured rectal artery aneurysm in a patient with neurofibromatosis
Nemoto Hidehiko; Mori Kensaku; Takei Yohei; Kikuchi S...
CVIR ENDOVASCULAR/5(1)/p.37, 2022-08-04 - Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)
Nakasya Akio; Hagiwara Yuya; Ikoma Tatsuki; Kurioka Y...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/27(4)/pp.684-694, 2022-04 - Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review
Y Hagiwara; Y Yamamoto; Y Inagaki; R Tomisaki; M Tsu...
INTERNAL MEDICINE/61(16)/pp.2449-2455, 2022-02 - Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
Jogo Tomoko; Nakamura Yoshiaki; Shitara Kohei; Bando ...
CLINICAL CANCER RESEARCH/27(20)/pp.5619-5627, 2021-10 - Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
Yamamoto Shun; Nagashima Kengo; Kawakami Takeshi; Mita...
BMC CANCER/21(1), 2021-10 - さらに表示...
- Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer